482 related articles for article (PubMed ID: 16249284)
1. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
Ehrmann DA; Liljenquist DR; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2006 Jan; 91(1):48-53. PubMed ID: 16249284
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
[TBL] [Abstract][Full Text] [Related]
3. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
4. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
Carmina E; Campagna AM; Lobo RA
Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
[TBL] [Abstract][Full Text] [Related]
5. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
8. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in adolescents with polycystic ovary syndrome.
Vrbíková J; Zamrazilová H; Sedláčková B; Šnajderová M
Gynecol Endocrinol; 2011 Oct; 27(10):820-2. PubMed ID: 20807165
[TBL] [Abstract][Full Text] [Related]
10. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.
Liang SJ; Liou TH; Lin HW; Hsu CS; Tzeng CR; Hsu MI
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1167-72. PubMed ID: 22497305
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.
Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482
[TBL] [Abstract][Full Text] [Related]
12. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
14. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
[TBL] [Abstract][Full Text] [Related]
15. Metabolic approaches to the subclassification of polycystic ovary syndrome.
Norman RJ; Masters SC; Hague W; Beng C; Pannall P; Wang JX
Fertil Steril; 1995 Feb; 63(2):329-35. PubMed ID: 7843439
[TBL] [Abstract][Full Text] [Related]
16. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
17. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
Coviello AD; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
20. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]